DCAT Week ’19: Supplier Expansion Roundups
By

By
What have been other important developments from CDMOs, CMOs, and other suppliers thus far in 2019? A look at DCAT member companies making the news. Here are the highlights of…

DCAT Week ’19: Executive Insights and Best Practices
By

By
What is on the minds of leading pharmaceutical industry executives? The DCAT Week ’19 education programs featured insight on key issues impacting the pharmaceutical industry, manufacturing, and supply. Changes in…

Pharma Industry Faces Slower Growth, Changing Business Models
By

By
Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, presented a challenging vision for drug companies at DCAT Week ’19 as the industry faces slowing global growth, evolving innovation strategies,…

CEOs, Senior Executives Highlight Strategies, M&A, and Expansions at DCAT Week
By

By
Chief executive officers and senior executives from DCAT member companies provided key updates on strategy, mergers and acquisitions, and expansions at the DCAT Member Company Announcement Forum held during DCAT…

DCAT Week ’19 Preview: Global Pharma Industry Outlook, Executive Insights and Nobel Laureate in Chemistry
By

By
How did the pharma industry perform in 2018, and what is the outlook for 2019 and beyond? What are the key drivers shaping drug-development and commercialization, and what is the…

Taking Supplier Relationship Management to the Next Level
By

By
Strategic partnerships are key in delivering value in supply management, so what are some ways in which companies are collaborating to achieve such value? DCAT Sharp Sourcing, which was held…

Optimizing the Pharma Customer–Supplier Relationship
By

By
How can pharmaceutical companies and suppliers best partner to achieve cost-efficiencies and drive value? A preview of DCAT Sharp Sourcing, to be held June 26, highlights best practices. The program…

Senior Executives Highlight Mergers and Acquisitions and Expansions at DCAT Week ’18
By

By
At the DCAT Member Company Announcement Forum, held during DCAT Week, senior executives from member companies of the Drug, Chemical & Associated Technologies Association (DCAT) provided the latest major news…

DCAT Week ’18: Biocon COO Highlights Company’s Growth Strategy
By

By
  Prasad BSVChief Operating OfficerBiocon Limited Prasad BSV, Chief Operating Officer (COO), Biocon Limited, discussed the company’s growth strategy to add solid-dosage manufacturing capabilities to complement the company’s current position…

DCAT Week ’18: Nosco President Discusses Company’s Growth Strategy in Wake of Two Key Acquisitions
By

By
  Russ HarafPresidentNosco Russ Haraf, President of Nosco, a pharmaceutical packaging company, outlined the expansion of the company’s capabilities following two major acquisitions and how they fit into the company’s…